Osaka, Japan

Motoyuki Miyamoto

This inventor holds 2 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2016-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoyuki Miyamoto. Retrieved from https://idiyas.com/inventor/motoyuki-miyamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Motoyuki Miyamoto: Innovator in Antipsychotic Agents

Introduction

Motoyuki Miyamoto is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antipsychotic agents. With a total of 2 patents, his work has garnered attention for its innovative approach to treatment.

Latest Patents

Miyamoto's latest patents include the development of piperazine-substituted benzothiophene derivatives as antipsychotic agents. These compounds are characterized by their superior solubility in oils such as sesame oil and benzyl benzoate. They offer a broader treatment spectrum, cause fewer side effects, and demonstrate improved tolerability and safety. The heterocyclic compounds he has developed are represented by a specific formula, which is detailed in the patent specifications.

Career Highlights

Miyamoto is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work is pivotal in advancing treatments for mental health conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Miyamoto collaborates with esteemed colleagues such as Hiroshi Yamashita and Yohji Sakurai. Their combined expertise contributes to the success of their projects and enhances the research environment at Otsuka Pharmaceutical.

Conclusion

Motoyuki Miyamoto's contributions to the field of antipsychotic agents reflect his dedication to innovation and patient care. His work continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…